I have been looking at this company the last week or so and i am keen to invest for the longer term. The limited results seem impressive, though only in phase 1 and 2, so commercialisation/approvals would appear to be several years away?. Partnerships or a potential takeover would obviously push the share price higher. So at 13 cents a share i suppose this is where the fair value is at given the stage the company is at with their trials and potential approvals several years away. Am i missing something here?
The CF33, Vaxinia and Oncarlytics Deal, page-166
-
- There are more pages in this discussion • 922 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $384.2K | 7.271M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 1723946 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 905438 | 6 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |